<?xml version="1.0"?>
<Document>

	<Sentence>
		<value>Rheumatoid arthritis (RA) is a long-term disease.</value>
		<pattern_crowdsource> [[Rheumatoid arthritis|C0003873]] (RA) is a long-term [[disease|C0012634]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Rheumatoid arthritis</surface-form>
				<RDF-ID>C0003873</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>long-term</surface-form>
				<RDF-ID>C0443252</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>disease</surface-form>
				<RDF-ID>C0012634</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0003873 ISA C0012634</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Infection, genes, and hormone changes may be linked to the disease.</value>
		<pattern_crowdsource> Infection, [[genes|C0017337]], and hormone changes may be linked to the [[disease|C0012634]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Infection</surface-form>
				<RDF-ID>C0009450</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>genes</surface-form>
				<RDF-ID>C0017337</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hormone changes</surface-form>
				<RDF-ID>C1134488</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>disease</surface-form>
				<RDF-ID>C0012634</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0017337 ASSOCIATED_WITH C0012634</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>It is much less common than osteoarthritis which is a condition that occurs in many people due to wear and tear on the joints as they age.</value>
		<pattern_crowdsource> It is much less common than [[osteoarthritis|C0029408]] which is a condition that occurs in many [[people|C0027361]] due to wear and [[tear|C0043246]] on the [[joints|C0022417]] as they age.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>common</surface-form>
				<RDF-ID>C0205214</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>osteoarthritis</surface-form>
				<RDF-ID>C0029408</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>condition</surface-form>
				<RDF-ID>C0348080</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>people</surface-form>
				<RDF-ID>C0027361</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>tear</surface-form>
				<RDF-ID>C0043246</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>joints</surface-form>
				<RDF-ID>C0022417</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>age</surface-form>
				<RDF-ID>C0001779</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0029408 OCCURS_IN C0027361</triple>
			<triple>C0029408 OCCURS_IN C0043246</triple>
			<triple>C0022417 LOCATION_OF C0043246</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Other symptoms include:  - Chest pain when taking a breath (pleurisy)  - Dry eyes and mouth (Sjogren syndrome)  - Eye burning, itching, and discharge  - Nodules under the skin (usually a sign of more severe disease)  - Numbness, tingling, or burning in the hands and feet  - Sleep difficulties</value>
		<pattern_crowdsource> Other symptoms include:  - Chest pain when taking a breath (pleurisy)  - Dry eyes and mouth (Sjogren syndrome)  - Eye burning, itching, and discharge  - Nodules under the skin (usually a sign of more severe disease)  - Numbness, [[tingling|C0423572]], or burning in the [[hands|C0018563]] and feet  - Sleep difficulties		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>symptoms</surface-form>
				<RDF-ID>C1457887</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Chest pain</surface-form>
				<RDF-ID>C0008031</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>breath</surface-form>
				<RDF-ID>C0225386</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>pleurisy</surface-form>
				<RDF-ID>C0032231</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Dry eyes</surface-form>
				<RDF-ID>C0314719</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>mouth</surface-form>
				<RDF-ID>C1278910</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Sjogren syndrome</surface-form>
				<RDF-ID>C1527336</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Eye burning</surface-form>
				<RDF-ID>C0851196</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>itching</surface-form>
				<RDF-ID>C0033774</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>discharge</surface-form>
				<RDF-ID>C0012621</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Nodules</surface-form>
				<RDF-ID>C0028259</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>skin</surface-form>
				<RDF-ID>C0037267</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>sign</surface-form>
				<RDF-ID>C0311392</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>more</surface-form>
				<RDF-ID>C0205172</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>severe</surface-form>
				<RDF-ID>C0205082</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>disease</surface-form>
				<RDF-ID>C0012634</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Numbness</surface-form>
				<RDF-ID>C0028643</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>tingling</surface-form>
				<RDF-ID>C0423572</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>burning</surface-form>
				<RDF-ID>C0175627</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hands</surface-form>
				<RDF-ID>C0018563</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>feet</surface-form>
				<RDF-ID>C0347981</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Sleep</surface-form>
				<RDF-ID>C0037313</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>difficulties</surface-form>
				<RDF-ID>C1299586</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0018563 LOCATION_OF C0423572</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Most people with RA will have some abnormal test results.</value>
		<pattern_crowdsource> Most [[people|C0027361]] with RA will have some abnormal [[test results|C0456984]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>people</surface-form>
				<RDF-ID>C0027361</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>abnormal</surface-form>
				<RDF-ID>C0205161</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>test results</surface-form>
				<RDF-ID>C0456984</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0456984 PROCESS_OF C0027361</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>However, some people will have normal results for all tests.</value>
		<pattern_crowdsource> However, some [[people|C0027361]] will have [[normal results|C0459422]] for all tests.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>people</surface-form>
				<RDF-ID>C0027361</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>normal results</surface-form>
				<RDF-ID>C0459422</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>tests</surface-form>
				<RDF-ID>C0392366</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0459422 PROCESS_OF C0027361</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>MEDICINES  Disease modifying antirheumatic drugs (DMARDs): These are often the drugs that are tried first in people with RA.</value>
		<pattern_crowdsource> [[MEDICINES|C0013227]]  [[Disease modifying antirheumatic drugs|C0242708]] (DMARDs): These are often the [[drugs|C0013227]] that are tried first in [[people|C0027361]] with RA.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>MEDICINES</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Disease modifying antirheumatic drugs</surface-form>
				<RDF-ID>C0242708</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>often</surface-form>
				<RDF-ID>C0332183</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>drugs</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>first</surface-form>
				<RDF-ID>C1279901</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>people</surface-form>
				<RDF-ID>C0027361</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0242708 ISA C0013227</triple>
			<triple>C0242708 ISA C0013227</triple>
			<triple>C0013227 TREATS C0027361</triple>
			<triple>C0242708 TREATS C0027361</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>- Methotrexate (Rheumatrex) is the most commonly used DMARD for rheumatoid arthritis.</value>
		<pattern_crowdsource> - [[Methotrexate|C0025677]] ([[Rheumatrex|C1513197]]) is the most commonly used [[DMARD|C0242708]] for [[rheumatoid arthritis|C0003873]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Methotrexate</surface-form>
				<RDF-ID>C0025677</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Rheumatrex</surface-form>
				<RDF-ID>C1513197</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>most</surface-form>
				<RDF-ID>C0205393</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>used</surface-form>
				<RDF-ID>C0042153</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>DMARD</surface-form>
				<RDF-ID>C0242708</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>rheumatoid arthritis</surface-form>
				<RDF-ID>C0003873</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C1513197 ISA C0025677</triple>
			<triple>C0242708 TREATS C0003873</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Leflunomide (Arava) and hydroxychloroquine may also be used.</value>
		<pattern_crowdsource> [[Leflunomide|C0063041]] ([[Arava|C0718644]]) and hydroxychloroquine may also be used.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Leflunomide</surface-form>
				<RDF-ID>C0063041</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Arava</surface-form>
				<RDF-ID>C0718644</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hydroxychloroquine</surface-form>
				<RDF-ID>C0020336</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0718644 ISA C0063041</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>- Sulfasalazine is an anti-inflammatory drug that is often combined with methotrexate and hydroxychloroquine (triple therapy).</value>
		<pattern_crowdsource> - [[Sulfasalazine|C0036078]] is an [[anti-inflammatory drug|C0003209]] that is often combined with [[methotrexate|C0025677]] and [[hydroxychloroquine|C0020336]] (triple [[therapy|C0087111]]).		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Sulfasalazine</surface-form>
				<RDF-ID>C0036078</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>anti-inflammatory drug</surface-form>
				<RDF-ID>C0003209</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>often</surface-form>
				<RDF-ID>C0332183</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>methotrexate</surface-form>
				<RDF-ID>C0025677</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hydroxychloroquine</surface-form>
				<RDF-ID>C0020336</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>triple</surface-form>
				<RDF-ID>C0205174</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>therapy</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0036078 ISA C0003209</triple>
			<triple>C0020336 ISA C0087111</triple>
			<triple>C0025677 ISA C0087111</triple>
			<triple>C0025677 COEXISTS_WITH C0003209</triple>
			<triple>C0020336 COEXISTS_WITH C0003209</triple>
			<triple>C0025677 COEXISTS_WITH C0036078</triple>
			<triple>C0020336 COEXISTS_WITH C0036078</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>- Although NSAIDs work well, long-term use can cause stomach problems, including ulcers and bleeding, and possible heart problems.</value>
		<pattern_crowdsource> - Although [[NSAIDs|C0003211]] work well, long-term use can cause [[stomach problems|C0577027]], including ulcers and bleeding, and possible [[heart problems|C0795691]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>NSAIDs</surface-form>
				<RDF-ID>C0003211</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>well</surface-form>
				<RDF-ID>C0205170</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>long-term</surface-form>
				<RDF-ID>C0443252</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>use</surface-form>
				<RDF-ID>C0042153</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>stomach problems</surface-form>
				<RDF-ID>C0577027</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>ulcers</surface-form>
				<RDF-ID>C0041582</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>bleeding</surface-form>
				<RDF-ID>C0019080</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>possible</surface-form>
				<RDF-ID>C0332149</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>heart problems</surface-form>
				<RDF-ID>C0795691</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0003211 CAUSES C0577027</triple>
			<triple>C0003211 CAUSES C0795691</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>- Celecoxib (Celebrex) is another anti-inflammatory drug.</value>
		<pattern_crowdsource> - [[Celecoxib|C0538927]] ([[Celebrex|C0719198]]) is another [[anti-inflammatory drug|C0003209]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Celecoxib</surface-form>
				<RDF-ID>C0538927</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Celebrex</surface-form>
				<RDF-ID>C0719198</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>anti-inflammatory drug</surface-form>
				<RDF-ID>C0003209</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0719198 ISA C0538927</triple>
			<triple>C0719198 ISA C0003209</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Drugs in this class (COX-2 inhibitors) may increase heart attack and stroke risk for some people.</value>
		<pattern_crowdsource> [[Drugs|C0013227]] in this class (COX-2 inhibitors) may increase [[heart attack|C0027051]] and stroke risk for some people.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Drugs</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>class</surface-form>
				<RDF-ID>C0456387</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>COX-2 inhibitors</surface-form>
				<RDF-ID>C1257954</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>heart attack</surface-form>
				<RDF-ID>C0027051</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>stroke risk</surface-form>
				<RDF-ID>C1277291</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>people</surface-form>
				<RDF-ID>C0027361</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0013227 AUGMENTS C0027051</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Antimalarial medications: This group of medicines includes hydroxychloroquine (Plaquenil).</value>
		<pattern_crowdsource> [[Antimalarial|C0003374]] [[medications|C0013227]]: This group of medicines includes [[hydroxychloroquine|C0020336]] ([[Plaquenil|C0699177]]).		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Antimalarial</surface-form>
				<RDF-ID>C0003374</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>medications</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>group</surface-form>
				<RDF-ID>C0441833</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>medicines</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hydroxychloroquine</surface-form>
				<RDF-ID>C0020336</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Plaquenil</surface-form>
				<RDF-ID>C0699177</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0003374 ISA C0013227</triple>
			<triple>C0699177 ISA C0020336</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Corticosteroids: These medicines work very well to reduce joint swelling and inflammation, but they can have long-term side effects.</value>
		<pattern_crowdsource> Corticosteroids: These [[medicines|C0013227]] work very well to reduce [[joint swelling|C0152031]] and [[inflammation|C0021368]], but they can have long-term side effects.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Corticosteroids</surface-form>
				<RDF-ID>C0001617</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>medicines</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>very</surface-form>
				<RDF-ID>C0442824</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>well</surface-form>
				<RDF-ID>C0205170</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>joint swelling</surface-form>
				<RDF-ID>C0152031</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>inflammation</surface-form>
				<RDF-ID>C0021368</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>side</surface-form>
				<RDF-ID>C0441987</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>long-term side effects</surface-form>
				<RDF-ID>C0023983</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0013227 PREVENTS C0152031</triple>
			<triple>C0013227 PREVENTS C0021368</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>There are different types of biologic agents:  - White blood cell modulators include: abatacept (Orencia) and rituximab (Rituxan)  - Tumor necrosis factor (TNF) inhibitors include: adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade), golimumab (Simponi), and certolizumab (Cimzia)  - Interleukin-6 (IL-6) inhibitors: tocilizumab (Actemra)    Biologic agents can be very helpful in treating rheumatoid arthritis.</value>
		<pattern_crowdsource> There are different types of biologic agents:  - White blood cell modulators include: abatacept (Orencia) and rituximab (Rituxan)  - Tumor necrosis factor (TNF) inhibitors include: [[adalimumab|C1122087]] ([[Humira|C1171255]]), [[etanercept|C0717758]] ([[Enbrel|C0720193]]), [[infliximab|C0666743]] ([[Remicade|C0723012]]), golimumab (Simponi), and certolizumab (Cimzia)  - Interleukin-6 (IL-6) inhibitors: tocilizumab (Actemra)    [[Biologic agents|C0005522]] can be very helpful in treating [[rheumatoid arthritis|C0003873]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>different</surface-form>
				<RDF-ID>C1547020</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>types</surface-form>
				<RDF-ID>C0332307</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>biologic agents</surface-form>
				<RDF-ID>C0005522</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>White blood cell</surface-form>
				<RDF-ID>C0023516</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>abatacept</surface-form>
				<RDF-ID>C1619966</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>rituximab</surface-form>
				<RDF-ID>C0393022</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Tumor necrosis factor</surface-form>
				<RDF-ID>C1456820</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>inhibitors</surface-form>
				<RDF-ID>C0243077</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>adalimumab</surface-form>
				<RDF-ID>C1122087</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Humira</surface-form>
				<RDF-ID>C1171255</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>etanercept</surface-form>
				<RDF-ID>C0717758</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Enbrel</surface-form>
				<RDF-ID>C0720193</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>infliximab</surface-form>
				<RDF-ID>C0666743</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Remicade</surface-form>
				<RDF-ID>C0723012</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Interleukin-6</surface-form>
				<RDF-ID>C0021760</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>inhibitors</surface-form>
				<RDF-ID>C0243077</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>tocilizumab</surface-form>
				<RDF-ID>C1609165</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Biologic agents</surface-form>
				<RDF-ID>C0005522</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>very</surface-form>
				<RDF-ID>C0442824</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>helpful</surface-form>
				<RDF-ID>C1552861</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>treating</surface-form>
				<RDF-ID>C1522326</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>rheumatoid arthritis</surface-form>
				<RDF-ID>C0003873</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C1171255 ISA C1122087</triple>
			<triple>C0720193 ISA C0717758</triple>
			<triple>C0723012 ISA C0666743</triple>
			<triple>C0005522 ASSOCIATED_WITH C0003873</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>may include total knee, hip replacement, ankle replacement, shoulder replacement, and others    PHYSICAL THERAPY  Range-of-motion exercises and exercise programs prescribed by a physical therapist can delay the loss of joint function and help keep muscles strong.</value>
		<pattern_crowdsource> may include total knee, [[hip replacement|C0392806]], ankle replacement, [[shoulder replacement|C0186623]], and others    PHYSICAL THERAPY  Range-of-motion exercises and exercise programs prescribed by a physical therapist can delay the loss of [[joint function|C1535551]] and help keep muscles strong.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>total</surface-form>
				<RDF-ID>C0439810</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>knee</surface-form>
				<RDF-ID>C0022742</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hip replacement</surface-form>
				<RDF-ID>C0392806</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>ankle</surface-form>
				<RDF-ID>C0003086</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>replacement</surface-form>
				<RDF-ID>C0559956</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>shoulder replacement</surface-form>
				<RDF-ID>C0186623</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>others    PHYSICAL THERAPY</surface-form>
				<RDF-ID>C0029709</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Range</surface-form>
				<RDF-ID>C1514721</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>motion</surface-form>
				<RDF-ID>C0026597</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>exercises</surface-form>
				<RDF-ID>C0015259</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>exercise</surface-form>
				<RDF-ID>C0015259</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>physical</surface-form>
				<RDF-ID>C0205485</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>therapist</surface-form>
				<RDF-ID>C0871525</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>loss</surface-form>
				<RDF-ID>C1517945</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>joint function</surface-form>
				<RDF-ID>C1535551</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>muscles</surface-form>
				<RDF-ID>C0026845</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>strong</surface-form>
				<RDF-ID>C0442821</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0186623 AFFECTS C1535551</triple>
			<triple>C0392806 AFFECTS C1535551</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Sometimes, therapists will use special machines to apply deep heat or electrical stimulation to reduce pain and improve joint movement.</value>
		<pattern_crowdsource> Sometimes, therapists will use special machines to apply [[deep heat|C0621652]] or electrical stimulation to reduce [[pain|C0030193]] and improve joint movement.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>therapists</surface-form>
				<RDF-ID>C0871525</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>machines</surface-form>
				<RDF-ID>C0336779</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>deep heat</surface-form>
				<RDF-ID>C0621652</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>electrical stimulation</surface-form>
				<RDF-ID>C0013786</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>pain</surface-form>
				<RDF-ID>C0030193</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>joint movement</surface-form>
				<RDF-ID>C0542330</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0621652 PREVENTS C0030193</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Other therapies that may help ease joint pain include:  - Joint protection techniques  - Heat and cold treatments  - Splints or orthotic devices to support and align joints  - Frequent rest periods between activities, as well as 8 to 10 hours of sleep per night    NUTRITION  Some people with RA may have intolerance or allergies to certain foods.</value>
		<pattern_crowdsource> Other [[therapies|C0087111]] that may help ease [[joint pain|C0003862]] include:  - Joint protection techniques  - Heat and cold treatments  - Splints or orthotic devices to support and align joints  - Frequent rest periods between activities, as well as 8 to 10 hours of sleep per night    NUTRITION  Some people with RA may have intolerance or allergies to certain foods.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>therapies</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>joint pain</surface-form>
				<RDF-ID>C0003862</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Joint</surface-form>
				<RDF-ID>C0392905</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>protection</surface-form>
				<RDF-ID>C1545588</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>techniques</surface-form>
				<RDF-ID>C0449851</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>treatments</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Splints</surface-form>
				<RDF-ID>C0038009</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>orthotic devices</surface-form>
				<RDF-ID>C0029365</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>joints</surface-form>
				<RDF-ID>C0392905</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Frequent</surface-form>
				<RDF-ID>C0332183</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>rest periods</surface-form>
				<RDF-ID>C0260207</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>activities</surface-form>
				<RDF-ID>C0441655</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>10 hours</surface-form>
				<RDF-ID>C1442445</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>sleep</surface-form>
				<RDF-ID>C0037313</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>night</surface-form>
				<RDF-ID>C0439552</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>NUTRITION</surface-form>
				<RDF-ID>C1521729</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>people</surface-form>
				<RDF-ID>C0027361</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>allergies</surface-form>
				<RDF-ID>C0020517</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>certain</surface-form>
				<RDF-ID>C0205423</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>foods</surface-form>
				<RDF-ID>C0016452</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0087111 TREATS C0003862</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>It may be helpful to eat foods rich in fish oils (omega-3 fatty acids).</value>
		<pattern_crowdsource> It may be helpful to eat foods rich in [[fish oils|C0016157]] ([[omega-3 fatty acids|C0015689]]).		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>helpful</surface-form>
				<RDF-ID>C1552861</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>foods</surface-form>
				<RDF-ID>C0016452</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>rich</surface-form>
				<RDF-ID>C0699759</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>fish oils</surface-form>
				<RDF-ID>C0016157</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>omega-3 fatty acids</surface-form>
				<RDF-ID>C0015689</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0015689 ISA C0016157</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>People with rheumatoid factor, the anti-CCP antibody, or subcutaneous nodules seem to have a more severe form of the disease.</value>
		<pattern_crowdsource> [[People|C0027361]] with [[rheumatoid factor|C0035448]], the [[anti-CCP antibody|C0003242]], or subcutaneous nodules seem to have a more severe form of the [[disease|C0012634]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>People</surface-form>
				<RDF-ID>C0027361</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>rheumatoid factor</surface-form>
				<RDF-ID>C0035448</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>CCP</surface-form>
				<RDF-ID></RDF-ID>
			</annotation>
			<annotation>
				<surface-form>anti-CCP antibody</surface-form>
				<RDF-ID>C0003242</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>subcutaneous nodules</surface-form>
				<RDF-ID>C0151811</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>more</surface-form>
				<RDF-ID>C0205172</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>severe</surface-form>
				<RDF-ID>C0205082</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>form</surface-form>
				<RDF-ID>C1522492</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>disease</surface-form>
				<RDF-ID>C0012634</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0035448 PART_OF C0027361</triple>
			<triple>C0003242 PART_OF C0027361</triple>
			<triple>C0012634 PROCESS_OF C0027361</triple>
			<triple>C0035448 ASSOCIATED_WITH C0012634</triple>
			<triple>C0003242 ASSOCIATED_WITH C0012634</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Early treatment with a three-drug combination known as "triple therapy", or with the biologic drugs, can decrease joint pain and damage.</value>
		<pattern_crowdsource> Early [[treatment|C0087111]] with a three-[[drug combination|C0013162]] known as "triple [[therapy|C0087111]]", or with the biologic [[drugs|C0013227]], can decrease [[joint pain|C0003862]] and damage.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Early</surface-form>
				<RDF-ID>C1279919</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>treatment</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>three</surface-form>
				<RDF-ID>C0205449</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>drug combination</surface-form>
				<RDF-ID>C0013162</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>triple</surface-form>
				<RDF-ID>C0205174</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>therapy</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>biologic</surface-form>
				<RDF-ID>C0205460</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>drugs</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>joint pain</surface-form>
				<RDF-ID>C0003862</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0087111 USES C0013162</triple>
			<triple>C0013227 PREVENTS C0003862</triple>
			<triple>C0087111 PREVENTS C0003862</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>These drugs are given by specialists called rheumatologists.</value>
		<pattern_crowdsource> These [[drugs|C0013227]] are given by [[specialists|C0087009]] called rheumatologists.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>drugs</surface-form>
				<RDF-ID>C0013227</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>specialists</surface-form>
				<RDF-ID>C0087009</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>rheumatologists</surface-form>
				<RDF-ID>C0334889</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0013227 ADMINISTERED_TO C0087009</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Complications may include:  - Damage to the lung tissue (rheumatoid lung)  - Increased risk of hardening of the arteries  - Spinal injury when the neck bones become damaged  - Inflammation of the blood vessels (rheumatoid vasculitis), which can lead to skin, nerve, heart, and brain problems  - Swelling and inflammation of the outer lining of the heart (pericarditis) and of the heart muscle (myocarditis), which can lead to congestive heart failure   The treatments for RA can also cause serious side effects.</value>
		<pattern_crowdsource> Complications may include:  - Damage to the lung tissue (rheumatoid lung)  - Increased risk of hardening of the arteries  - Spinal injury when the [[neck|C0027530]] [[bones|C0262950]] become damaged  - [[Inflammation|C0021368]] of the [[blood vessels|C0005847]] (rheumatoid vasculitis), which can lead to skin, nerve, heart, and [[brain problems  - Swelling|C1527311]] and [[inflammation|C0021368]] of the outer lining of the heart (pericarditis) and of the heart muscle (myocarditis), which can lead to [[congestive heart failure|C0018802]]   The treatments for RA can also cause serious [[side effects|C0879626]].		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>Complications</surface-form>
				<RDF-ID>C0009566</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>lung tissue</surface-form>
				<RDF-ID>C0819757</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>rheumatoid lung</surface-form>
				<RDF-ID>C0994344</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Increased</surface-form>
				<RDF-ID>C0205217</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>risk</surface-form>
				<RDF-ID>C0035647</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>hardening</surface-form>
				<RDF-ID>C0702118</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>arteries</surface-form>
				<RDF-ID>C0003842</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Spinal injury</surface-form>
				<RDF-ID>C0037937</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>neck</surface-form>
				<RDF-ID>C0027530</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>bones</surface-form>
				<RDF-ID>C0262950</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>Inflammation</surface-form>
				<RDF-ID>C0021368</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>blood vessels</surface-form>
				<RDF-ID>C0005847</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>rheumatoid vasculitis</surface-form>
				<RDF-ID>C0240903</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>skin</surface-form>
				<RDF-ID>C0037267</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>nerve</surface-form>
				<RDF-ID>C0027740</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>heart</surface-form>
				<RDF-ID>C0018787</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>problems</surface-form>
				<RDF-ID>C1546466</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>brain problems  - Swelling</surface-form>
				<RDF-ID>C1527311</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>inflammation</surface-form>
				<RDF-ID>C0021368</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>outer</surface-form>
				<RDF-ID>C0205101</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>heart</surface-form>
				<RDF-ID>C0018787</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>pericarditis</surface-form>
				<RDF-ID>C0031046</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>heart muscle</surface-form>
				<RDF-ID>C0027061</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>myocarditis</surface-form>
				<RDF-ID>C0027059</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>congestive heart failure</surface-form>
				<RDF-ID>C0018802</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>treatments</surface-form>
				<RDF-ID>C0087111</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>serious</surface-form>
				<RDF-ID>C0205404</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>side effects</surface-form>
				<RDF-ID>C0879626</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C0027530 LOCATION_OF C0262950</triple>
			<triple>C0005847 LOCATION_OF C0021368</triple>
			<triple>C0005847 LOCATION_OF C0021368</triple>
			<triple>C0021368 CAUSES C0018802</triple>
			<triple>C0021368 CAUSES C0018802</triple>
			<triple>C1527311 CAUSES C0879626</triple>
		</triples>
	</Sentence>
	<Sentence>
		<value>Call your health care provider if you think you have symptoms of rheumatoid arthritis.</value>
		<pattern_crowdsource> Call your [[health care provider|C0018724]] if you think you have [[symptoms|C1457887]] of rheumatoid arthritis.		</pattern_crowdsource>
		<annotations>
			<annotation>
				<surface-form>health care provider</surface-form>
				<RDF-ID>C0018724</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>symptoms</surface-form>
				<RDF-ID>C1457887</RDF-ID>
			</annotation>
			<annotation>
				<surface-form>rheumatoid arthritis</surface-form>
				<RDF-ID>C0003873</RDF-ID>
			</annotation>
		</annotations>
		<triples>
			<triple>C1457887 PROCESS_OF C0018724</triple>
		</triples>
	</Sentence>

</Document>

